Oncternal Therapeutics Inc. sell marge
Start price
05.11.20
/
50%
€2.50
Target price
05.11.21
-
Performance (%)
47.44%
End price
06.11.21
€3.69
Summary
This prediction ended on 06.11.21 with a price of €3.69. The SELL prediction by marge for Oncternal Therapeutics Inc. was trending in the completely wrong direction and closed with a performance of 47.44%. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Oncternal Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 4.094% | 3.543% | 17.404% | 20.326% |
| iShares Nasdaq 100 | 1.424% | 0.512% | 39.212% | 55.365% |
| iShares Nikkei 225® | -1.572% | -4.633% | 15.731% | 2.146% |
| iShares S&P 500 | 1.822% | 0.963% | 30.396% | 45.950% |
Comments by marge for this prediction
In the thread Oncternal Therapeutics Inc. diskutieren
Sell GTx Inc.
@christoph ,Oncternal Therapeutics, Inc. hat die Fusion mit GTx, Inc. am 7. Juni 2019 abgeschlossen. Das kombinierte Unternehmen wird unter dem Namen Oncternal Therapeutics, Inc. firmieren und seine Aktien werden am 10. Juni 2019 unter dem Ticker an der Nasdaq-Börse gehandelt Symbol "ONCT".
In the thread Trading Oncternal Therapeutics Inc.
Die von marge gewählte maximale Laufzeit wurde überschritten